Exelixis, Inc. is a biopharmaceutical company, which engages in the developing and commercializing small molecule therapies for the treatment of cancer. Its brands include COMETRIQ and cobimetinib. The company focuses on their proprietary resources and development and commercialization of cabozantinib. Exelixis was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.

Recent Equity Price Chart

Loading...
Filter Trades By Expiration: Latest Trades | Expiring This Week | Long Term | All Trades

Bullish Trades

Call trades that are bought on or above the market's asking price OR put trades that are sold on or less than the market's bid price - expecting a move to the updside.



Type Expiration DTE Bid Purchase Price Ask Spread Strike Total Traded Size Volume Trade Condition Timestamp Notes
Call Login To View Login To View Login To View Login To View Login To View Login To View Login To View $475,000.00 Login To View Login To View 18 days ago Login To View
Call Login To View Login To View Login To View Login To View Login To View Login To View Login To View $432,000.00 Login To View Login To View about 1 month ago Login To View

Bearish Trades

Put trades that are bought on or above the market's asking price OR call trades that are sold on or less than the market's bid price - expecting a move to the downside.



Type Expiration DTE Bid Purchase Price Ask Spread Strike Total Traded Size Volume Trade Condition Timestamp Notes
Call Login To View Login To View Login To View Login To View Login To View Login To View Login To View $402,500.00 Login To View Login To View 6 months ago Login To View
Call Login To View Login To View Login To View Login To View Login To View Login To View Login To View $89,000.00 Login To View Login To View 7 days ago Login To View